Holdings
Baker Bros. Advisors LP
As of Jun 30, 2026, Baker Bros. Advisors LP reported 75 positions worth US$18.9B. Largest: Incyte Corporation, Beone Medicines Ltd. Class A and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Incyte Corporation | 30.8M | US$3.49B | +17,918 | Jun 30, 2026 |
| Beone Medicines Ltd. Class A | 8.8M | US$2.51B | +2,514 | Jun 30, 2026 |
| Revolution Medicines, Inc. | 11.4M | US$2.14B | +1.89M | Jun 30, 2026 |
| Madrigal Pharmaceuticals, Inc. | 2.14M | US$1.15B | +1,430 | Jun 30, 2026 |
| Acadia Pharmaceuticals Inc. | 42.9M | US$1.09B | +16,214 | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 8.66M | US$993M | no change | Jun 30, 2026 |
| Insmed Incorporated | 8.8M | US$938M | +1.38M | Jun 30, 2026 |
| Celcuity Inc. | 7.92M | US$828M | no change | Jun 30, 2026 |
| Kodiak Sciences Inc | 19.9M | US$776M | no change | Jun 30, 2026 |
| Rhythm Pharmaceuticals, Inc. | 5.6M | US$622M | no change | Jun 30, 2026 |